Predominance of CIN versus MSI in the development of rectal cancer at young age

BMC Cancer

Table 3 Summary of molecular genetic alterations

Tumor no.	DI	MSI	MSH2	MLH1	B-cat.	TP53	KRAS mut.
1	2.1	-	+	+	C	-	-
2	1.1	-	+	+	C	-	-
3	1.4	-	+	+	C	+	12, GGT->GAT
4	4.5	-	+	+	C	+	12, GGT->GTT
5	2.0	-	+	+	C	+	-
6	1.4	-	+	+	C	+	12, GGT->TGT
7	1.7	-	+	+	C	-	-
8	1.0	+	-	+	M	-	-
9	1.5	-	+	+	M	+	-
10	1.0	+	-	+	C	+	13, GGC->GAC
11	1.0	-	+	+	C	-	-
12	1.0	+	-	+	N	-	-
13	1.6	-	+	+	C	-	-
14	1.0	-	+	+	N	+	-
15	1.0	-	+	+	C	+	-
16	1.0	-	+	+	M	+	-
17	1.0	-	+	+	M	-	-
18	1.1	-	+	+	C	+	-
19	1.1	-	+	+	C	+	-
20	1.3	-	+	+	N	-	-
21	1.8	-	+	+	C	+	-
22	1.3	-	+	+	N	-	-
23	1.2	-	+	+	C	-	-
24	1.7	-	+	+	N	-	-
25	1.0	-	+	+	M	+	-
26	2.0	-	+	+	N	+	-
27	1.2	-	+	+	C	+	12, GGT->GAT
28	1.6	-	+	+	C	+	-
29	1.2	-	+	+	C	+	12, GGT->AGT
30	1.1	-	+	+	C	+	-

ISSN: 1471-2407